Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab

Overview of attention for article published in Annals of Neurology, December 2010

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news: 1 news outlet
blogs: 2 blogs

patent: 1 patent

Citations

dimensions_citation: 299 Dimensions

Readers on

mendeley: 267 Mendeley

Summary News Blogs Patents Dimensions citations

So far, Altmetric has seen 1 news story.

WANTED: Biomarkers for Drug Trials in Frontotemporal Dementia

Alzforum, 25 Apr 2016

25 Apr 2016 At a recent workshop hosted for the Frontotemporal Dementia Study Group on March 31 and April 1 in Washington, D.C.…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.